Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer

Clinical trial NCT01635465 · UNKNOWN

Trial details

NCT number: NCT01635465
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Anthracycline-pretreated Metastatic Breast Cancer

Start date: 2016-11-01
Primary completion: 2016-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.